Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKB | Q96GD4 | 16/20 | 0.81 |
| ▸ | AURKA | O14965 | 13/20 | 0.81 |
| ▸ | LCK | P06239 | 3/20 | 0.68 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.63 |
| ▸ | KDR | P35968 | 2/20 | 0.63 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.63 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.63 |
| ▸ | EGFR | P00533 | 1/20 | 0.63 |
| ▸ | CDK2 | P24941 | 1/20 | 0.63 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.63 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.63 |
| ▸ | PTK6 | Q13882 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14507450 | 0.90 | AURKB (1.00) | AURKBAURKALCKCHEK1KDR | |
| SCHEMBL14507770 | 0.88 | AURKB (0.62) | AURKBAURKALCKCHEK1KDR | |
| SCHEMBL14529991 | 0.88 | CHEK1 (0.64) | AURKBAURKALCKCHEK1KDR | |
| SCHEMBL8246082 | 0.88 | CHEK1 (0.64) | AURKBAURKALCKCHEK1KDR | |
| SCHEMBL12404569 | 0.83 | AURKB (0.70) | AURKBAURKALCKCHEK1KDR | |
| SCHEMBL14530381 | 0.83 | AURKA (0.56) | AURKBAURKALCKCHEK1KDR | |
| SCHEMBL13954903 | 0.83 | AURKB (0.56) | AURKBAURKALCKCHEK1KDR | |
| SCHEMBL13845550 | 0.83 | AURKB (0.68) | AURKBAURKALCKCHEK1KDR | |
| SCHEMBL13954832 | 0.82 | AURKB (0.68) | AURKBAURKALCKCHEK1KDR | |
| SCHEMBL13955001 | 0.82 | LCK (0.72) | AURKBAURKALCKCHEK1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009017701-A2 | ANTI-MITOTIC AGENT AND AURORA KINASE INHIBITOR COMBINATION AS ANTI-CANCER TREATMENT | SCHERING CORPORATION (US) | 2009-02-05 | — | — | WO | disclosed |